← Back to news

Markets

Oracle Plans to Raise Up to $50 Billion for AI Infrastructure Buildout

Y

IDEXX (IDXX) Q4 2025 Earnings Call Transcript

Y

BMO Stays Bullish on Primo Brands Corporation (PRMB) Despite Near-Term Estimate Reset

Y

AstraZeneca Shares Start Trading in US After Listing Upgrade

Y

Dutch Bros Inc. (BROS) Positioned for Continued Same-Store Sales Momentum, Says Citi

Y

The ONE Group Hospitality, Inc. (STKS) Seen as Long-Term Opportunity Despite Q4 Revenue Miss

Y

OPEC+ Overproducers Update Compensation Cuts

Y

GenLogs raises $60M Series B to enhance supply chain intelligence and security

Y

JPMorgan Raises Celsius Holdings Inc (CELH) Price Target, Sees Earnings Upside From PepsiCo Partnership and Alani Nu Growth

Y

Stocks Gain Steam After Opening Lower

Y

Do Wall Street Analysts Like CrowdStrike Stock?

Y

With Shares Down 10% After Its Earnings Call, Is Microsoft a Buy?

Y

Black Diamond Therapeutics, Inc. (BDTX) Price Target Trimmed as Piper Updates Biotech Models and 2026 Catalyst Tracker

Y

1 Social Security Trick That Could Get You Larger Benefits

Y

Altimmune, Inc. (ALT) Gains Analyst Support Ahead of Phase 3 MASH Development

Y

Piper Sandler See Label Expansion Potential for ImmunityBio, Inc. (IBRX)’s ANKTIVA Following QUILT Data

Y

Kroger Stock Outlook: Is Wall Street Bullish or Bearish?

Y

Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets

Y

Here is Why Hedge Funds Favor Advance Auto Parts (AAP)

Y

Autoliv (ALV) Drives Some Near Term Optimism Despite Affordability Concerns

Y

Favorable Sector Outlook Bodes Well for Visteon (VC)

Y

Latest Zero-Emission Offerings Spark Bullish Views on Garrett Motion (GTX)

Y

H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)’s PKP2 Program

Y

Goodyear (GT) Set to Benefit From Favorable Replacement Tire Market Potential

Y

Aptiv (APTV) Looking at More Realistic Value and Growth Propositions

Y

2026 Labeled as a Transition Year for Mobileye (MBLY)

Y

AutoZone (AZO) Showing Ambition Towards Accelerating Store Growth

Y

Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT)

Y

Hyperliquid's HYPE higher by 10% on plans to add prediction markets and options

Y

H.C. Wainwright Flag KRRO-121 as Independent Value Driver for Korro Bio, Inc. (KRRO)

Y

Alphabet Inc.’s Google Adds More Gemini AI Features to the Chrome Browser

Y

Here Is Why TSMC Could Be Investing More In the US?

Y

Alibaba Group Holding’s Robovan Unit Set to Invest in Zelos Technology, WSJ Reports

Y

Analysts Remain Bullish on Advanced Micro Devices Despite Rumours of MI450-Series Chips Behind Schedule

Y

Morgan Stanley Upgrades Johnson & Johnson to Overweight, Increases PT to $262

Y

Cathie Wood Remains Bullish on Broadcom Amid AI and Datacenter Exposure

Y

Are Coins a Safe-Haven Asset? What Experts Say for 2026

Y

‘We live on Social Security and pensions’: I’m in my 70s and my house needs repairs. Do I take out a $50K loan — or sell stocks?

Y

Palantir Earnings Arrive Just as Stock Could Use Some Good News

Y

Are Wall Street Analysts Bullish on Morgan Stanley Stock?

Y

Brookfield to Buy Peakstone Realty Trust in $1.2 Billion Deal

Y

C3.ai (AI) Stays Central to AI Debate as Capital Intensity Challenges Investor Confidence

Y

Russia’s Largest Crypto Miner BitRiver Faces Bankruptcy as CEO Under House Arrest: Report

Y

RIA Edge 100 Firms Add Clients, Employees at Roughly Same Pace

Y

'It's All On Paper' – Gymshark Founder, Worth $1.4B, Says You Should Never Link Self-Worth With Money, Thinks It's 'Wildly Unproductive' Way To Live

Y

Tom Lee's BitMine Immersion added 41,000 ether as paper losses rise to $6 billion

Y

1 Under-the-Radar AI Stock With Explosive Growth Potential

Y

H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)’s Carvykti Despite Sales Miss

Y

Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results

Y

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)

Y